Workflow
GUOTAI EPOINT SOFTWARE CO.(688232)
icon
Search documents
新点软件(688232.SH)业绩快报:2025年归母净利润3504.05万元,同比下降82.85%
Ge Long Hui A P P· 2026-02-27 09:32
格隆汇2月27日丨新点软件(688232.SH)公布2025年度业绩快报,报告期内,公司实现营业总收入18.33亿 元,同比下降14.60%;归属于母公司所有者的净利润3504.05万元,同比下降82.85%;归属于母公司所 有者的扣除非经常性损益的净利润-2954.32万元,同比下降126.02%。 2025年公司总收入较上年同期下滑,主要是G端业务受客户预算的影响,部分项目从立项到验收的整体 进度有所放缓;B端收入基本持平,占营收比重为48.67%,提升5.91个百分点。 ...
新点软件(688232) - 新点软件2026年第一次临时股东会会议资料
2026-02-27 08:30
证券代码:688232 证券简称:新点软件 国泰新点软件股份有限公司 2026年第一次临时股东会 会 议 资 料 2026 年 2 月 国泰新点软件股份有限公司 2026 年第一次临时股东会会议资料 目 录 | 2026 年第一次临时股东会会议须知 2 | | | --- | --- | | 2026 年第一次临时股东会会议议程 4 | | | 议案一:关于部分募投项目结项并将节余募集资金投资建设新项目、其他募投 | | | 项目及永久补充流动资金的议案 | 6 | | 议案二:关于暂时调整部分募集资金投资项目闲置场地用途的议案 | 18 | 1 国泰新点软件股份有限公司 2026 年第一次临时股东会会议资料 国泰新点软件股份有限公司 2026 年第一次临时股东会会议须知 为维护国泰新点软件股份有限公司(以下简称"公司")全体股东的合法 权益,确保股东会的正常秩序和议事效率,保证会议的顺利进行,根据《中华 人民共和国公司法》《中华人民共和国证券法》《上市公司股东会规则》以及 《国泰新点软件股份有限公司章程》(以下简称"《公司章程》")、《国泰 新点软件股份有限公司股东会议事规则》等相关规定,制定本须知: 一、 ...
新点软件(688232) - 2025 Q4 - 年度业绩
2026-02-27 08:05
本公告所载2025年度主要财务数据为初步核算数据,未经会计师事务所审计, 具体数据以国泰新点软件股份有限公司(以下简称"公司")2025年年度报告为 准,请投资者注意投资风险。 一、2025 年度主要财务数据和指标 单位:万元 证券代码:688232 证券简称:新点软件 公告编号:2026-013 国泰新点软件股份有限公司 2025 年度业绩快报公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 公司为把握行业发展机遇,巩固核心技术竞争优势,持续在高端人才引进、 科技创新研发等领域保持战略性投入。同时公司通过优化组织架构、削减非必要 开支、提升资源利用效率等措施,加强对成本、研发、销售及管理费用的精细化 管控,报告期内期间费用同比下降 7.74%。持续加强应收账款回款管理,全年销 售回款到账约为 22 亿元,公司经营活动产生的现金流量净额为净流入,持续健 康的现金流表现,为未来的高质量发展奠定基础,随着公司商业模式转型不断推 进,经营质量将持续改善。 2026 年,公司将持续深化内部市场化改革,极大调动每个员工的积极性; ...
新点软件:2025年净利润3504.05万元,同比下降82.85%
Xin Lang Cai Jing· 2026-02-27 07:52
新点软件公告,2025年实现营业总收入18.33亿元,同比下降14.60%;净利润3504.05万元,同比下降 82.85%。2025年公司总收入较上年同期下滑,主要是G端业务受客户预算的影响,部分项目从立项到验 收的整体进度有所放缓;B端收入基本持平,占营收比重为48.67%,提升5.91个百分点。 ...
春节前9家龙头集体出手!7家回购超5亿,2家增持近3400万
Sou Hu Cai Jing· 2026-02-23 01:14
Summary of Key Points Core Viewpoint - Several leading companies across various industries have recently announced share repurchase plans, reflecting their confidence in long-term value and commitment to enhancing shareholder returns [11][22]. Group 1: Share Repurchase Plans - New Point Software completed a share repurchase of 1.8272 million shares, accounting for 0.57% of total shares, with a total expenditure of approximately 49.36 million yuan [1][16]. - Quzhou Dongfeng New Materials Group plans to repurchase shares worth between 50 million to 100 million yuan, with an upper price limit of 6.48 yuan per share, potentially acquiring 7.716 million to 15.432 million shares [3][12]. - Step Long Pharmaceutical completed a repurchase of 6.8564 million shares, representing 0.65% of total shares, with a total payment of approximately 118.5 million yuan [4][14]. - Huatai Medical announced a repurchase plan with a budget of 150 million to 200 million yuan, aiming to buy back 47,620 to 63,490 shares at a maximum price of 315 yuan per share [6][18]. - Hengtong Co., Ltd. plans to repurchase shares worth between 80 million to 100 million yuan, with a maximum price of 14.50 yuan per share, intending to cancel the repurchased shares [6][15]. Group 2: Shareholder Actions - Yinfeng Co. has repurchased 9.43 million shares, accounting for 2.14% of total shares, with a total expenditure of approximately 60.89 million yuan [7][12]. - Spring and Autumn Electronics announced the cancellation of 9.1369 million repurchased shares, reducing total shares from 456 million to 447 million [8][12]. - Yinzuo Co.'s major shareholder completed a share increase of 5.5066 million shares, representing 1.06% of total shares, with an expenditure of approximately 31.63 million yuan [8][12]. - Changshu Bank's executives have increased their holdings by 293,400 shares, with a total expenditure of approximately 2.07 million yuan [9][12]. Group 3: Industry Overview - The companies involved span various sectors, including software services, new materials, pharmaceutical manufacturing, medical devices, logistics, textile printing, consumer electronics, retail, and financial services [11][12]. - New Point Software is a leader in smart procurement, while Step Long Pharmaceutical is a key player in traditional Chinese medicine for cardiovascular diseases [11][18]. - Huatai Medical is recognized as a benchmark for domestic cardiovascular intervention devices, and Hengtong Co. is a core service provider in petrochemical logistics [11][18]. Group 4: Market Context - The share repurchase and increase actions occurred primarily between late January and early February 2026, coinciding with a traditionally sensitive period in the capital market [12][21]. - The actions taken by these companies contrast with the weak performance of the Hong Kong market, particularly in the internet technology sector, highlighting a proactive stance by these firms [22].
新点软件:累计回购约183万股
Mei Ri Jing Ji Xin Wen· 2026-02-13 10:41
(记者 王晓波) 每经AI快讯,新点软件2月13日晚间发布公告称,截至本公告披露日,公司已完成本次回购。公司通过 上海证券交易所交易系统以集中竞价交易方式累计回购股份约183万股,占公司总股本约3.22亿股的比 例为0.57%,回购成交的最高价为31.15元/股,最低价为24.21元/股,回购均价为27.01元/股,支付的资 金总额为人民币约4936万元。公司回购股票金额已超过回购方案中回购资金总额下限且未超过回购资金 总额上限,本次回购方案实施完毕。 每经头条(nbdtoutiao)——上市公司净利从暴增9倍到突然预亏超2亿元,董事长为何自掏5000万元补 窟窿?50亿元信托理财也去向成谜,股民直呼看不懂 ...
2月13日晚间重要公告一览
Xi Niu Cai Jing· 2026-02-13 10:24
Group 1 - RuiLian New Materials reported a total operating revenue of 1.677 billion yuan for 2025, an increase of 14.95% year-on-year, with a net profit of 311 million yuan, up 23.48% year-on-year [1] - China Shenhua's subsidiary, Guoneng Qingyuan Power, successfully put its fourth generator unit into commercial operation, expected to provide approximately 20 billion kWh of clean energy annually [2] - Qijiang Airlines announced a 6.04% year-on-year decline in passenger turnover for January 2026, with a passenger load factor of 84.03%, up 1.61% year-on-year [3] Group 2 - QiZheng Tibetan Medicine reported a total operating revenue of 2.416 billion yuan for 2025, a year-on-year increase of 3.34%, with a net profit of 646 million yuan, up 10.98% year-on-year [5] - QiaoYin Co. announced the termination of its artificial intelligence industry headquarters project due to changes in investment cooperation conditions [6] - New Point Software plans to use 90.81 million yuan of surplus raised funds for new projects, including AI-driven software development [7] Group 3 - High Measurement Co. announced plans for major shareholders and executives to reduce their holdings by up to 3.19% of the company's shares [8] - SAIC Group's subsidiary plans to establish a private equity fund with an initial scale of 2.5 billion yuan, focusing on solid-state batteries and chip localization [9] - Tianqi Lithium announced the resignation of its deputy general manager due to personal career planning [10] Group 4 - ZhongKong Technology reported a total operating revenue of 8.051 billion yuan for 2025, a decrease of 11.90%, with a net profit of 450 million yuan, down 59.70% year-on-year [11] - Spring Airlines reported a 6.28% year-on-year increase in total passenger volume for January 2026, with a total available ton-kilometers of 57,008.37 [12] - Qifan Cable's controlling shareholder reduced its stake by 3% through various trading methods [13] Group 5 - China Chemical signed contracts worth a total of 36.925 billion yuan in January 2026, with significant contracts exceeding 5 billion yuan totaling 11.371 billion yuan [19] - SaiTuo Bio received a CEP certificate for its raw material drug Betamethasone, which is used to treat allergies and autoimmune inflammation [20] - Giant Star Agriculture reported a sales revenue of 649 million yuan from commodity fat pigs in January 2026, with a sales volume of 404,400 pigs [23] Group 6 - Qinglong Pipe Industry's subsidiary won a 146 million yuan pipeline project [24] - Changshan Pharmaceutical announced that some of its products are expected to be selected for national centralized procurement [26] - Yangdian Technology completed the transfer of 12.96% of its shares through an agreement [27] Group 7 - Deepin Technology's investment fund introduced new limited partners and adjusted the capital contributions of some partners [28] - Qingyun Technology plans to pledge 25% of its shares for a loan application of up to 30 million yuan [29] - LaiMei Pharmaceutical reported a 57.20% year-on-year decline in net profit for 2025 [30] Group 8 - YouLiDe reported a 16.88% year-on-year decline in net profit for 2025, with total operating revenue of 1.221 billion yuan, up 7.99% [31] - Warner Pharmaceutical reported a net profit of 241 million yuan for 2025, an increase of 46.95% year-on-year [32] - LianRui New Materials reported a net profit of 293 million yuan for 2025, an increase of 16.42% year-on-year [33] Group 9 - HuaQin Technology expects a 24.28% year-on-year decrease in net profit for 2025, with projected revenue of 1.251 billion yuan, up 9.83% [34] - QiPai Technology's shareholder subscribed for 6.3 million shares, accounting for 5.49% of the total share capital [35] - Qilin Security's shareholders completed their planned share reductions without exceeding the original plan [36] Group 10 - Dameng Data announced the lifting of the detention of its senior vice president, allowing him to resume his duties [37] - Haiyou Engineering won a contract for the "NFPS COMP5" project worth approximately 4 billion USD, with the company's share exceeding 800 million USD [38] - Yatai Group plans to sell 20.81% of its shares in Northeast Securities, pending confirmation of financial statements [39]
新点软件(688232) - 新点软件关于股份回购实施结果暨股份变动的公告
2026-02-13 09:02
证券代码:688232 证券简称:新点软件 公告编号:2026-012 国泰新点软件股份有限公司 关于股份回购实施结果暨股份变动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 一、回购审批情况和回购方案内容 2025 年 9 月 24 日,公司召开第二届董事会第二十次会议,审议通过了《关于 以集中竞价交易方式回购股份方案的议案》,同意公司使用自有资金以集中竞价交 易方式回购公司已发行的部分人民币普通股(A 股)股票,回购的股份将在未来 适宜时机全部用于股权激励及/或员工持股计划,回购价格不超过 42 元/股(含), 回购资金总额不低于人民币 3,000 万元(含),不超过人民币 5,000 万元(含), 回购期限自公司董事会审议通过回购方案之日起 12 个月内。 具体内容详见公司于 2025 年 9 月 25 日、2025 年 9 月 27 日披露在上海证券交 易所网站(www.sse.com.cn)的《新点软件关于以集中竞价交易方式回购股份的 预案》(公告编号:2025-039)、《新点软件关于以集中 ...
新点软件(688232) - 国泰海通证券股份有限公司关于国泰新点软件股份有限公司部分募投项目结项并将节余募集资金投资建设新项目、其他募投项目及永久补充流动资金的核查意见
2026-02-13 09:01
国泰海通证券股份有限公司 | 发行名称 | 2021 | | | 年首次公开发行人民币普通股(A | 股) | | --- | --- | --- | --- | --- | --- | | 募集资金总额 | 4,000,425,000.00 | | | 元 | | | 募集资金净额 | 3,827,268,179.49 | | | 元 | | | 募集资金到账时间 | 2021 年 12 | 11 | 月 | 日 | | 一、募集资金基本情况 为规范公司募集资金管理和使用,维护投资者权益,公司依照规定开设了募 集资金专项账户(以下简称"募集资金专户"),对募集资金进行专户存储,并与 保荐机构、募集资金专户监管银行签订了《募集资金专户存储三方监管协议》; 与实施募投项目的子公司、保荐机构、存放募集资金的商业银行签订了《募集资 金专户存储四方监管协议》。 二、本次募投项目结项及募集资金节余情况 关于国泰新点软件股份有限公司 部分募投项目结项并将节余募集资金投资建设新项目、 其他募投项目及永久补充流动资金的核查意见 上海证券交易所: 国泰海通证券股份有限公司(以下简称"保荐机构")作为国泰新点软件股 份有限公司( ...
新点软件(688232) - 国泰海通证券股份有限公司关于国泰新点软件股份有限公司暂时调整部分募集资金投资项目闲置场地用途的核查意见
2026-02-13 09:01
国泰海通证券股份有限公司 关于国泰新点软件股份有限公司 暂时调整部分募集资金投资项目闲置场地用途的核查意见 上海证券交易所: 国泰海通证券股份有限公司(以下简称"保荐机构")作为国泰新点软件股 份有限公司(以下简称"新点软件"或"公司")首次公开发行股票并在科创板 上市及持续督导的保荐机构,根据《中华人民共和国公司法》《中华人民共和国 证券法》《证券发行上市保荐业务管理办法》《上市公司募集资金监管规则》《上 海证券交易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监管 指引第 1 号——规范运作》等法律法规的相关规定,对新点软件部分募投项目结 项并将节余募集资金投资建设新项目、其他募投项目及永久补充流动资金事项进 行了核查,核查情况及核查意见如下: 一、募集资金基本情况 三、暂时调整部分募集资金投资项目闲置场地用途的情况 目前,新点软件区域运营中心建设项目已达到预定使用状态并投入使用,原 2 计划用于强化区域运营中心地位,增强运营中心的研发、销售、管理职能。因近 年公司实施降本增效,团队规模未进行大幅扩张,故新点软件区域运营中心建设 项目部分场地会出现暂时闲置的情况。为提高募投项目场地的使用效率,在 ...